Regulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics Research Post published:March 4, 2021 Post category:Press Release
MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury Post published:March 4, 2021 Post category:Press Release
atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round Post published:March 3, 2021 Post category:Press Release
Cybin Inc. Announces Uplisting to OTCQB Venture Market Post published:March 3, 2021 Post category:Press Release
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing Post published:March 3, 2021 Post category:Press Release
Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board Post published:March 3, 2021 Post category:Press Release
Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs Post published:March 3, 2021 Post category:Press Release
Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonists Show Significant Reduction in Binge Eating Post published:March 3, 2021 Post category:Press Release
Red Light Holland’s iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert Post published:March 3, 2021 Post category:Press Release
MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company’s Clinical Research Post published:March 3, 2021 Post category:Press Release